Furthermore, continuous efforts by the government to reduce hospital stays and curb healthcare expenditure, establishments attempting to provide effective and rapid diagnostic results, and improvement in technology with the provision of cheap and high-quality medical solutions aimed at achieving lab automation are some factors contributing to the growth of the PoC Lipid Test Market.
Further key findings from the study suggest:
Alere Cholestech LDx market was estimated at over 6,400 units in 2014 and is expected to reach over 11,000 units by 2022, growing at a CAGR of 7.8% over the forecast period. The analyzer is included in the CLIA waived test list and is certified by the Cholesterol Reference Method Laboratory Method Network (CRMLN) program and Lipid Standardization Program (LSP)
Browse Detailed Report With TOC at:
Global launch of Roche Cobas b 101 at the end of 2013 excluding the U.S. region and the introduction of Samsung LABGEO PT10 in the Indian market are expected to drive the point of care Lipid Test market at a lucrative rate over the next six years.
Consumables Piccolo Express by Abaxis market was valued over 1,000 thousand units in 2014 owing to the presence of CLIA-waived capillary or venous lipid and liver panel used for monitoring statin medications results. Abaxis is the only company, which provides a venous or capillary or CLIA waived Lipid and Liver panel.
Hyperlipidemia is the largest application area for PoC Lipid Test industry with revenue of over USD 55 million in 2014. Whereas, hypertriglyceridemia is the fastest growing application area with the expected growth rate of 5.6% during the forecast period due to increasing incidences of hypertriglyceridemia and the introduction of technologically advanced products such as CardioChek PA by PTS Diagnostics.
Biotechnology Market Research Related Reports:
Global Bisphenol F Industry 2016 Market:
Global MABS Industry 2016 Market:
Europe constituted the largest share of over 35% in 2014 of the total market. Presence of favorable regulations and initiatives pertaining to the development of healthcare infrastructure, and also high disease prevalence levels in the region are the major factors responsible for its growth.
Asia Pacific accounted for over 19% share in 2014 of the total market. However, the market share of this region is estimated to increase at a CAGR of 5.8% by 2022 due to increasing demand for rapid diagnostic testing in developing countries such as India and China.
Some key players of this market include Abaxis Inc., Roche Diagnostics, Alere Inc., Polymer Technology Systems (PTS Diagnostics), and Samsung Electronics Corporation. Alere with its product portfolio including Alere Cholestech LDx and Alere Afinion AS100 Analyzer was the leader in the POC lipid testing market with a share of over 22% in 2014.
Request A Sample copy of This Report at:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Our Website: http://www.hexareports.com
Company Name: Hexa Reports
Contact Person: Ryan Shaw
Email: Send Email
Address:Felton Office Plaza, 6265 Highway 9
Country: United States